Figure-1 (11005a48 13fd 4c6d A024 1e39e3528e45 01)
Letrozole Tablet, Film Coated
Product Images NDC 24979-726
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Letrozole (NDC 24979-726). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Upsher-smith Laboratories, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure-1 (Figure 1 Disease Free Survival Median Follow Up 73 Months Itt Approach)
Figure-3 (Figure 2 Kaplan Meier Estimates Of Time To Progression Tamoxifen Study)
Figure-4 (Figure 3 Survival By Randomized Treatment Arm)
This is a description of a figure showing survival rates based on different treatment arms in a randomized study.*
Figure-5 (Figure 4 Kaplan Meier Estimates Of Time To Progression Megestrol Acetate Study)
This description indicates the presence of Figure 4, showing Kaplan-Meier Estimates of Time to Progression in a study involving Megestrol Acetate. It likely presents data on the progression of a particular condition over time.*
Figure-6 (Figure 5 Kaplan Meier Estimates Of Time To Progression Amino)
This is a description of Figure 5 showing Kaplan-Meier Estimates of Time to Progression in the Aminoglutethimide Study.*
Image Description (Label 90)
Image Description (Label)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
